Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 83

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 83
---
. We do not carry “key person” insurance for
our executives or staff so that replacing them might be challenging due to our inability to pay premium salaries or signing bonuses, together
with the scarcity of individuals with the required breadth of skills and experience in our industry. We might struggle to attract, train,
retain, or motivate them given the numerous competing pharmaceutical and biotechnology companies.

Our reliance on a central team consisting of a limited number
of employees who provide various administrative, research and development and other services to all our subsidiaries presents operational
challenges that may adversely affect our business.

As of December 31, 2024, we had 19 full-time employees and
two part-time employees whom we rely on for drug development planning, employee relations, financing accounting matters and other
support services for our company and all of its subsidiaries. These individuals may not have sufficient time and bandwidth to perform
effectively their respective responsibilities, potentially hindering the achievement of our goals and jeopardizing the execution of our
business strategy. While our current structure helps us minimize certain overhead expenses, the relatively small size of our central team
limits our ability to allocate enough personnel, time, and resources to effectively manage our subsidiaries and investments creation of
effective drug development plans, employee recruitment and retention, and overseeing financial and accounting matters. Members of our
central team may lack sufficient information about various aspects of our subsidiaries’ business and operations to adequately address
these responsibilities.

43

We will need to expand our organization, and we may experience
difficulties in managing this growth, which could disrupt our operations.

We anticipate expanding our roster of full-time employees, which
will require significant management time and attention to hire qualified employees, which will divert a disproportionate amount of attention
away from our daily operations and dedicate significant time to overseeing these growth initiatives. We will face challenges in effectively
managing the expansion of our operations, which could lead to operational errors, missed business prospects, employee attrition, and decreased
productivity among those who remain. Anticipated growth could necessitate substantial capital investments and potentially divert financial
resources from other projects, including the advancement of additional product candidates. If our management team struggles to manage
our growth effectively, it could lead to higher-than-expected expenses, curtailed revenue generation and growth capabilities, and
potential obstacles in executing our business strategy. The success of our future financial performance and our ability to effectively
bring product candidates to market and maintain competitiveness will hinge, in part, on our